INDICATORS OF SUBOPTIMAL THERAPY AMONG CROHN’S DISEASE PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ANTAGONISTS: RESULTS FROM A MULTINATIONAL STUDY

Alessandro Armuzzi  1     James Lindsay  2     Reema Mody  3     Bernd Bokemeyer  4     Javier Gisbert  5     Laurent Peyrin-Biroulet  6     Geoffrey C. Nguyen     Jean Siebenaler     Örjan Åkerborg     Michael Smyth    
1 IBD Unit, Complesso Integrato Columbus,Catholic University,Rome,Italy
2 Department of Gastroenterology,Barts Health NHS Trust,London,United Kingdom
3 Takeda Pharmaceuticals International, Inc.,Deerfield,United States
4 Gastroenterology Practice,Minden,Germany
5 Hospital Universitario de La Princesa, IIS-IP and CIBEREHD,Madrid,Spain
6 CHU d

Conference
UEG Week 2015

Citation
United European Gastroenterology Journal; 2015: 2 (Supplement 1)

Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Social Sharing